Published in J Clin Virol on July 01, 2002
Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev (2006) 6.03
Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993-1996). Eur J Clin Microbiol Infect Dis (2007) 3.50
Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology (2003) 1.45
Herpes simplex encephalitis with two false-negative cerebrospinal fluid PCR tests and review of negative PCR results in the clinical setting. Case Rep Neurol (2011) 0.93
Rapid virological diagnosis of central nervous system infections by use of a multiplex reverse transcription-PCR DNA microarray. J Clin Microbiol (2011) 0.89
Rapid and direct detection of herpes simplex virus in cerebrospinal fluid by use of a commercial real-time PCR assay. J Clin Microbiol (2014) 0.85
Positive PCR for enterovirus in the cerebrospinal fluid of a child with acute disseminated encephalomyelitis. J Neurol (2004) 0.82
Herpesvirus infections of the central nervous system in immunocompromised patients. Ther Adv Neurol Disord (2012) 0.81
Invader plus method detects herpes simplex virus in cerebrospinal fluid and simultaneously differentiates types 1 and 2. J Clin Microbiol (2006) 0.81
Virological diagnosis of central nervous system infections by use of PCR coupled with mass spectrometry analysis of cerebrospinal fluid samples. J Clin Microbiol (2013) 0.80
Cellular players in the herpes simplex virus dependent apoptosis balancing act. Viruses (2009) 0.79
Real-time PCR detection of human herpesvirus 1-5 in patients lacking clinical signs of a viral CNS infection. BMC Infect Dis (2011) 0.78
Acute parkinsonism as first manifestation of systemic lupus erythematosus unmasked by CMV infection. Neurol Sci (2014) 0.77
Epstein-barr virus encephalitis in infancy. West Indian Med J (2014) 0.75
Patients with an acute zonal occult outer retinopathy-like illness rapidly improve with valacyclovir treatment. Am J Ophthalmol (2010) 0.75
Subacute herpes simplex virus type 1 encephalitis as an initial presentation of chronic lymphocytic leukemia and multiple sclerosis: a case report. J Med Case Rep (2011) 0.75
Delayed Diagnosis of Tuberculous Meningitis Misdiagnosed as Herpes Simplex Virus-1 Encephalitis With the FilmArray Syndromic Polymerase Chain Reaction Panel. Open Forum Infect Dis (2016) 0.75
Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med (2005) 7.54
Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med (2000) 6.43
Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited. Neurology (1996) 4.02
Influenza vaccination of pregnant women and protection of their infants. N Engl J Med (2014) 3.68
Does Toll-like receptor 3 play a biological role in virus infections? Virology (2004) 2.73
Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol (2004) 2.71
Concussion in sports. Guidelines for the prevention of catastrophic outcome. JAMA (1991) 2.53
Electron transport chain defects in Alzheimer's disease brain. Neurology (1994) 2.51
West Nile virus neuroinvasive disease. Ann Neurol (2006) 2.42
Primary intraosseous meningioma. Case report. J Neurosurg (1995) 2.28
Toxic leukoencephalopathy. N Engl J Med (2001) 2.27
Human herpesvirus 8 DNA in CNS lymphomas from patients with and without AIDS. Neurology (1998) 2.17
Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J Infect Dis (2003) 1.91
Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab. Arch Neurol (2008) 1.88
Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol (2011) 1.83
Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin. Arch Pathol Lab Med (2003) 1.75
Pandemic influenza A H1N1 2009 infection versus vaccination: a cohort study comparing immune responses in pregnancy. PLoS One (2012) 1.55
Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science (1981) 1.52
Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child. J Infect Dis (2003) 1.50
Proximal nerve root spinal hemangioblastomas: presentation of three cases, MR appearance, and literature review. Surg Neurol (2004) 1.49
Herpesvirus infections of the nervous system. Nat Clin Pract Neurol (2007) 1.48
A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma. J Neurooncol (1994) 1.47
Epstein-Barr and other herpesvirus infections in patients with early onset type 1 diabetes treated with daclizumab and mycophenolate mofetil. Clin Infect Dis (2012) 1.47
CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology (2005) 1.45
Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev (2004) 1.42
A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol (2009) 1.42
Effect of rituximab on human in vivo antibody immune responses. J Allergy Clin Immunol (2011) 1.39
Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system. Ann Neurol (2002) 1.38
The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol (1995) 1.36
Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old. J Acquir Immune Defic Syndr (2010) 1.35
Diffuse Lewy body disease and progressive dementia. Neurology (1988) 1.31
Lymphomatosis cerebri as a cause of white matter dementia. Hum Pathol (2005) 1.30
Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates. Antimicrob Agents Chemother (2006) 1.28
An adult case of leukoencephalopathy with intracranial calcifications and cysts. Neurology (2006) 1.28
MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts. EMBO J (2003) 1.27
Glutathione binding to the Bcl-2 homology-3 domain groove: a molecular basis for Bcl-2 antioxidant function at mitochondria. J Biol Chem (2007) 1.26
Dual infections of the central nervous system with Epstein-Barr virus. J Infect Dis (2004) 1.24
Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol (1988) 1.24
Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors. J Neurovirol (2002) 1.23
Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I. Clin Cancer Res (2011) 1.22
Bell's palsy--is glucocorticoid treatment enough? N Engl J Med (2007) 1.22
West Nile virus meningoencephalitis. Nat Clin Pract Neurol (2006) 1.22
Central pontine myelinolysis at autopsy; a twelve year retrospective analysis. J Neurol Sci (1996) 1.22
An algorithmic approach to the brain biopsy--part II. Arch Pathol Lab Med (2006) 1.21
Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens. Antimicrob Agents Chemother (2007) 1.21
How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients. J Clin Microbiol (2005) 1.21
Preherpetic neuralgia. Neurology (1991) 1.20
Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists. Arch Dermatol (2009) 1.19
Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response. J Allergy Clin Immunol (2011) 1.19
Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading. J Neurol Sci (2000) 1.19
Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies. J Acquir Immune Defic Syndr (2005) 1.19
Apoptosis in animal models of virus-induced disease. Nat Rev Microbiol (2009) 1.19
N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease. J Neurol Sci (2001) 1.18
Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo. J Virol (2004) 1.18
Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels. J Virol (2002) 1.18
Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. J Infect Dis (2006) 1.17
The value of cerebrospinal fluid antiviral antibody in the diagnosis of neurologic disease produced by varicella zoster virus. J Neurol Sci (1998) 1.17
Two distinct phases of virus-induced nuclear factor kappa B regulation enhance tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in virus-infected cells. J Biol Chem (2003) 1.14
Brain metastases from hepatocellular carcinoma in US patients. J Neurooncol (2006) 1.14
Wallenberg syndrome caused by CSF metastasis from malignant intraventricular meningioma. Clin Neuropathol (1986) 1.14
Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors. Endocrinology (2011) 1.14
JNK regulates the release of proapoptotic mitochondrial factors in reovirus-infected cells. J Virol (2004) 1.13
Relationship of Kaposi sarcoma (KS)-associated herpesvirus viremia and KS disease in Zimbabwe. Clin Infect Dis (2003) 1.13
Minocycline delays disease onset and mortality in reovirus encephalitis. Exp Neurol (2005) 1.11
Recurrent dermatomal vesicular skin lesions: a clue to diagnosis of herpes simplex virus 2 meningitis. Arch Neurol (2003) 1.09
The effects of toluene on the central nervous system. J Neuropathol Exp Neurol (2004) 1.09
Growth hormone tumor histological subtypes predict response to surgical and medical therapy. Endocrine (2014) 1.09
Neurobehavioral presentations of brain neoplasms. West J Med (1995) 1.09
Fulminant ascending paralysis as a delayed sequela of diethylene glycol (Sterno) ingestion. Neurology (2002) 1.08
Regional differences in viral growth and central nervous system injury correlate with apoptosis. J Virol (2004) 1.08
Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021. Pediatrics (2007) 1.08
Cytomegalovirus infection in the era of HAART: fewer reactivations and more immunity. J Antimicrob Chemother (2004) 1.08
Hematological neoplasms with first presentation as spinal cord compression syndromes: a 10-year retrospective series and review of the literature. Clin Neuropathol (2003) 1.07
A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella. Pediatr Infect Dis J (2009) 1.06
History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls. Am J Epidemiol (2005) 1.05
Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains. J Neurol Sci (2000) 1.05
The uninvited guest: JC virus infection of neurons in PML. Neurology (2003) 1.05
Simian varicella virus infects ganglia before rash in experimentally infected monkeys. Virology (2001) 1.04
PARP1 expression in pediatric central nervous system tumors. Pediatr Blood Cancer (2009) 1.04
Reovirus-induced alterations in gene expression related to cell cycle regulation. J Virol (2002) 1.03
Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses. In Vitro Cell Dev Biol (1992) 1.03
Progressive multifocal leukoencephalopathy: can we reduce risk in patients receiving biological immunomodulatory therapies? Ann Neurol (2010) 1.03
Genetic characterization of gliomas arising in patients with multiple sclerosis. J Neurooncol (2012) 1.02
Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2010) 1.02
Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response. J Infect Dis (2005) 1.02
Unique molecular characteristics of radiation-induced glioblastoma. J Neuropathol Exp Neurol (2007) 1.02
The immunoglobulin G heavy chain repertoire in multiple sclerosis plaques is distinct from the heavy chain repertoire in peripheral blood lymphocytes. Clin Immunol (2001) 1.01
Novel strategy for treatment of viral central nervous system infection by using a cell-permeating inhibitor of c-Jun N-terminal kinase. J Virol (2007) 1.01
Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients. Clin Transplant (2009) 1.01
Progressive multifocal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of patients with and without AIDS. Arch Neurol (2002) 1.01
Central nervous system apoptosis in human herpes simplex virus and cytomegalovirus encephalitis. J Infect Dis (2002) 1.01
Reovirus-induced alteration in expression of apoptosis and DNA repair genes with potential roles in viral pathogenesis. J Virol (2003) 1.00
Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults. J Infect Dis (2012) 1.00
Sudden deterioration and death in patients with benign tumors of the third ventricle area. J Neurosurg (1986) 1.00
Infectious simian varicella virus expressing the green fluorescent protein. J Neurovirol (1998) 0.99
Osteochondroma of the convexity: pathologic-neuroimaging correlates of a lesion that mimics high-grade meningioma. J Neurooncol (2009) 0.98
Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine. Vaccine (2009) 0.98